Novo Nordisk Investor
Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases. Its main offerings include pioneering scientific breakthroughs and expanding access to their medicines, with the ultimate goal of preventing and curing disease.
Invests into
Founded Date:
1923-01-01
Investor Type:
Venture Funds
Headquarters:
Bagsværd, Hovedstaden, Denmark, Europe
Number Of Exists:
5
Number Of Investments Funding Rounds:
21
Founders:
August Krogh,Marie Krogh
Category:
Pharma & Medical
City:
Bagsværd
Region:
Hovedstaden
Country:
Denmark
Number Of Investments/Funding Rounds:
21